CAG
ABBV icon

Crestwood Advisors Group’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$21.9M Sell
118,089
-1,004
-0.8% -$186K 0.39% 70
2025
Q1
$25M Buy
119,093
+6,072
+5% +$1.27M 0.47% 63
2024
Q4
$20.1M Buy
113,021
+2,305
+2% +$410K 0.38% 69
2024
Q3
$21.9M Buy
110,716
+1,652
+2% +$326K 0.42% 70
2024
Q2
$18.7M Sell
109,064
-225
-0.2% -$38.6K 0.39% 71
2024
Q1
$19.9M Sell
109,289
-937
-0.9% -$171K 0.43% 67
2023
Q4
$17.1M Sell
110,226
-78
-0.1% -$12.1K 0.4% 67
2023
Q3
$16.4M Buy
110,304
+97,799
+782% +$14.6M 0.43% 65
2023
Q2
$1.68M Buy
12,505
+982
+9% +$132K 0.05% 116
2023
Q1
$1.84M Sell
11,523
-1,592
-12% -$254K 0.06% 111
2022
Q4
$2.12M Sell
13,115
-1,183
-8% -$191K 0.07% 110
2022
Q3
$1.92M Buy
14,298
+126
+0.9% +$16.9K 0.07% 116
2022
Q2
$2.17M Sell
14,172
-1,613
-10% -$247K 0.07% 115
2022
Q1
$2.56M Sell
15,785
-1,060
-6% -$172K 0.07% 116
2021
Q4
$2.28M Buy
16,845
+4,912
+41% +$665K 0.06% 117
2021
Q3
$1.29M Buy
11,933
+515
+5% +$55.5K 0.04% 139
2021
Q2
$1.29M Buy
11,418
+430
+4% +$48.4K 0.04% 141
2021
Q1
$1.19M Sell
10,988
-491
-4% -$53.1K 0.04% 140
2020
Q4
$1.23M Buy
11,479
+898
+8% +$96.2K 0.04% 134
2020
Q3
$927K Buy
10,581
+1,338
+14% +$117K 0.03% 130
2020
Q2
$907K Buy
9,243
+611
+7% +$60K 0.04% 125
2020
Q1
$658K Sell
8,632
-90
-1% -$6.86K 0.03% 135
2019
Q4
$772K Buy
8,722
+200
+2% +$17.7K 0.03% 148
2019
Q3
$645K Buy
8,522
+93
+1% +$7.04K 0.03% 153
2019
Q2
$613K Buy
+8,429
New +$613K 0.03% 148
2018
Q1
Sell
-2,541
Closed -$246K 179
2017
Q4
$246K Buy
+2,541
New +$246K 0.02% 158
2017
Q2
Sell
-1,408
Closed -$94K 159
2017
Q1
$94K Buy
+1,408
New +$94K 0.01% 197
2016
Q3
Sell
-4,632
Closed -$287K 130
2016
Q2
$287K Buy
4,632
+230
+5% +$14.3K 0.04% 107
2016
Q1
$251K Sell
4,402
-195
-4% -$11.1K 0.03% 119
2015
Q4
$272K Buy
+4,597
New +$272K 0.03% 121
2015
Q1
Sell
-3,074
Closed -$201K 146
2014
Q4
$201K Buy
+3,074
New +$201K 0.03% 139